Verona Pharma to host conference call

Conference call to discuss top-line data from three-day Phase 2 clinical pharmacology trial evaluating the effect of two different doses of nebulized ensifentrine will be held on January 14 at 8 am.

Webcast: https://investors.veronapharma.com/events-and-presentations/events
https://thefly.com/landingPageNews.php?id=2847923